A carregar...
Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
Glioblastoma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody against the vascular endothelial growth factor receptor, has increasingly been used in the treatment of recurrent glioblastoma. It has...
Na minha lista:
| Publicado no: | Brain Tumor Res Treat |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433944/ https://ncbi.nlm.nih.gov/pubmed/28516072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14791/btrt.2017.5.1.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|